Fluorescein

Fluorescein

SCHEMBL5409874

N=C(N)NCCCC(N)C(=O)O.O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccccc21

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACES1PR1S1PR4S1PR5

The experimentally established mechanism targets of Fluorescein. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 10/20 0.58
MAPT P10636 3/20 0.58
MEN1 O00255 2/20 0.58
HTT P42858 2/20 0.58
KMT2A Q03164 2/20 0.58
HPGD P15428 2/20 0.58
CYP2C19 P33261 1/20 0.58
RECQL P46063 1/20 0.58
BLM P54132 1/20 0.58
SMAD3 P84022 1/20 0.58
PRMT1 Q99873 1/20 0.58
ACE2 Q9BYF1 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
NAALAD2 Q9Y3Q0 3/20 0.46
ALB P02768 1/20 0.46
ITPR3 Q14573 1/20 0.44
LMNA P02545 2/20 0.43
ALOX12 P18054 2/20 0.43
POLB P06746 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluorescein SCHEMBL8373796 0.90 FTO (0.47) FTOMAPTMEN1HTTKMT2A
SCHEMBL5409887 0.88 FTO (0.52) FTOMAPTMEN1HTTKMT2A
Fluorescein SCHEMBL27084635 0.82 FTO (0.58) FTOMAPTMEN1HTTKMT2A
Fluorescein SCHEMBL1981171 0.81 FTO (0.70) FTOMAPTMEN1HTTKMT2A
Fluorescein SCHEMBL28230527 0.81 FTO (0.81) FTOMAPTMEN1HTTKMT2A
Fluorescein SCHEMBL3508466 0.78 FTO (0.89) FTOMAPTMEN1HTTKMT2A
Fluorescein SCHEMBL10940300 0.78 FTO (0.79) FTOMAPTMEN1HTTKMT2A
Fluorescein SCHEMBL27157739 0.77 FTO (0.92) FTOMAPTMEN1HTTKMT2A
Fluorescein SCHEMBL21194999 0.77 FTO (0.97) FTOMAPTMEN1HTTKMT2A
SCHEMBL7136416 0.77 ALB (0.56) FTOMAPTMEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070087377-A1 Methods and compositions for reverse translation MIRARI BIOSCIENCES, INC. (US) 2007-04-19 US disclosed
US-7169894-B2 Methods and compositions for reverse translation MIRARI BIOSCIENCES, INC. (US) 2007-01-30 US disclosed
US-20030100000-A1 Methods and compositions for reverse translation MIRARI BIOSCIENCES, INC. 2003-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030100000-A1 Methods and compositions for reverse translation RNGTT, CPSF1, RNMT FTO 3243/4885MAPT 3410/4885MEN1 2782/4885
US-20070087377-A1 Methods and compositions for reverse translation RNGTT, CPSF1, RNMT FTO 3243/4885MAPT 3410/4885MEN1 2782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.